news
New initiative to accelerate development of universal influenza vaccines
Universal Influenza Vaccine Initiative will address the underlying scientific barrier impeding the development of broadly protective, universal influenza vaccines...
List view / Grid view
Influenza
news
Influenza virus mutations prevented during vaccine production
Duke researchers used a bivalent virus from chicken cells that packaged twice as much protein as a monovalent virus, and vaccinated mice with either the bivalent or monovalent vaccine
news
Microneedle patches for flu vaccination prove successful in first human clinical trial
Small skin patches with dissolvable microneedles were safe and well-tolerated, generated robust immunity against influenza, could be self-administered by study participants and were strongly preferred over shots.
news
CHMP issues positive opinion of AstraZeneca’s pandemic influenza vaccine
5 April 2016 | By Victoria White
This recommendation allows a vaccine containing a strain of pandemic potential to be developed and authorised in advance of a pandemic being declared...
news
FSA grants Fast Track designation for MEDI8852
7 March 2016 | By Victoria White
MedImmune has received Fast Track designation from the FDA for MEDI8852 for the treatment of patients hospitalised with Type A strain influenza...
news
GSK submits sBLA seeking expanded indication for Flulaval Quadrivalent
3 February 2016 | By Victoria White
The submission seeks an expanded indication for Flulaval Quadrivalent in the US for children six months through 35 months of age...
article
The universal flu vaccine race
5 January 2016 | By Victoria White, European Pharmaceutical Review
A number of pharmaceutical companies see great potential in a universal flu vaccine, each hoping they will be the first to gain regulatory approval of their candidates. European Pharmaceutical Review spoke with Gregory Stoloff, CEO of one such company, SEEK, to find out more...
news
SEEK’s universal flu vaccine is one step closer
12 November 2015 | By Victoria White
FLU-v is a peptide-based vaccine that stimulates a cytotoxic T lymphocyte and non-neutralising antibody response against influenza. FLU-v may have potential as a cross-protective vaccine for multiple strains of influenza...
news
ESCMID calls for universal flu vaccination for healthcare works
4 November 2015 | By Victoria White
ESCMID believes that one vital tool to increase the adoption of flu vaccinations among healthcare professionals is to establish hospital-based league tables throughout Europe...
news
GSK begins shipping 2015-16 US flu vaccines
17 July 2015 | By Victoria White
GSK has begun shipping Flaurix Quadrivalent (flu vaccine) doses to US healthcare providers and expects to begin shipping Flulaval Quadrivalent in August...
news
Sanofi Pasteur ships first 2015-2016 seasonal influenza vaccine doses in US
14 July 2015 | By Victoria White
The FDA has released the first doses of Sanofi Pasteur’s Fluzone influenza vaccine for shipment for the 2015-2016 influenza season in the US...
news
Flu vaccine shows low effectiveness against the main circulating strain seen so far this season
6 February 2015 | By Public Health England
Flu vaccination remains important for other strains that still may circulate this winter...
news
France’s National Research Agency selects the OPTIVAC project and contributes €600,000 ($772,000) to improve the efficacy of influenza vaccines
27 October 2014 | By Imaxio
Imaxio announces that it has been awarded funding of EUR 600,000 (USD 772,000) by the French National Research Agency (Agence Nationale de la Recherche, ANR) for the OPTIVAC project 'leveraging On t-cell immune resPonse To Improve influenza VACcines'...
news
Calixar and VirPath develop an innovative manufacturing process for high performance influenza vaccines
23 September 2014 | By Andrew Lloyd & Associates
A new antigens formulation against pandemic flu (A H1N1 virus) proved six times more effective than other vaccines...
news
European Medicines Agency invites comments on new overarching guidance for the development of influenza vaccines
31 July 2014 | By The European Medicines Agency
The European Medicines Agency has released the second module of a new overarching guideline on influenza vaccines for a six-month public consultation...
